CARDIFF ONCOLOGY, INC. (CRDF) Free cash flow 2016–2025
CARDIFF ONCOLOGY, INC. (CRDF) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$38.0MFY2025 · since FY2016: -$31.9M → -$38.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.0M | -0.5% |
| FY2024 | -$37.8M | -20.0% |
| FY2023 | -$31.5M | +9.6% |
| FY2022 | -$34.8M | -49.8% |
| FY2021 | -$23.2M | -40.7% |
| FY2020 | -$16.5M | -23.9% |
| FY2019 | -$13.3M | -1.0% |
| FY2018 | -$13.2M | +43.5% |
| FY2017 | -$23.4M | +26.6% |
| FY2016 | -$31.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice